Local Institution
Mumbai 400067
0 studies enrolling now · 16 studies all time
What they study most
Bipolar Disorder, Breast Cancer, Chronic Hepatitis B, Crohn's Disease, Diabetes, Diabetes Mellitus, Type 2, Hepato Cellular Carcinoma (HCC), Leukemia, Myeloid Leukemia, Chronic, Pulmonary Embolism, Type 2 Diabetes, Type 2 Diabetes Mellitus
Studies at this site
- A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib — Completed
- A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania — Completed
- Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease — Stopped early
- Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection — Completed
- Add-on to Thiazolidinedione (TZD) Failures — Completed
- A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia — Completed
- First Line Hepato Cellular Carcinoma (HCC) — Completed
- Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer — Completed
- Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness — Completed
- Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin — Completed
- Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
- A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone — Completed
- A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode — Withdrawn before enrolling
- A Study of Abatacept in Patients With Active Crohn's Disease — Stopped early
- Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed